Search research articles
Contact Us
Filters
Showing results (351-360 of 443) with videos related to
Page
of 45
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)
|
April 7, 2019
Deletion of Biliverdin Reductase A in Myeloid Cells Promotes Chemokine Expression and Chemotaxis in Part via a Complement C5a--C5aR1 Pathway
Kavita Bisht, Giacomo Canesin, Tasneem Cheytan, et al.
Expert Review of Neurotherapeutics
|
May 25, 2019
Gut microbiota in ALS: possible role in pathogenesis?
Pamela A McCombe, Robert D Henderson, Aven Lee, et al.
Cancer
|
March 10, 2001
Clinicopathologic analysis of patients with adult rhabdomyosarcoma
W G Hawkins, A Hoos, C R Antonescu, et al.
Drug Delivery and Translational Research
|
November 21, 2021
Sustained-release ketamine-loaded lipid-particulate system: in vivo assessment in mice
Weizhi Xu, Faheem Maqbool, Vinod Kumar, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 10, 2005
Increased potency of a novel complement factor 5a receptor antagonist in a rat model of inflammatory bowel disease
Trent M Woodruff, Sandra Pollitt, Lavinia M Proctor, et al.
Inorganic Chemistry
|
June 1, 2014
Flexible binding of PNP pincer ligands to monomeric iron complexes
Kathlyn L Fillman, Elizabeth A Bielinski, Timothy J Schmeier, et al.
Brain Communications
|
October 9, 2020
Monocytes and neutrophils are associated with clinical features in amyotrophic lateral sclerosis
Raquel B McGill, Frederik J Steyn, Shyuan T Ngo, et al.
Journal of Hepatology
|
May 26, 2004
Protective effect of a human C5a receptor antagonist against hepatic ischaemia-reperfusion injury in rats
Thiruma V Arumugam, Trent M Woodruff, Shelli Z Stocks, et al.
The Journal of Infectious Diseases
|
February 21, 2018
Chronic Helminth Infection Perturbs the Gut-Brain Axis, Promotes Neuropathology, and Alters Behavior
Paul R Giacomin, Ann Katrin Kraeuter, Eduardo A Albornoz, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 30, 2009
Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer's disease
Maria I Fonseca, Rahasson R Ager, Shu-Hui Chu, et al.
Page
of 45
Search research articles
Search
Showing results (351-360 of 443) with videos related to
Sort By:
Page
of 45
Journal of Immunology (Baltimore, Md. : 1950)
|
April 7, 2019
Deletion of Biliverdin Reductase A in Myeloid Cells Promotes Chemokine Expression and Chemotaxis in Part via a Complement C5a--C5aR1 Pathway
Kavita Bisht, Giacomo Canesin, Tasneem Cheytan, et al.
Expert Review of Neurotherapeutics
|
May 25, 2019
Gut microbiota in ALS: possible role in pathogenesis?
Pamela A McCombe, Robert D Henderson, Aven Lee, et al.
Cancer
|
March 10, 2001
Clinicopathologic analysis of patients with adult rhabdomyosarcoma
W G Hawkins, A Hoos, C R Antonescu, et al.
Drug Delivery and Translational Research
|
November 21, 2021
Sustained-release ketamine-loaded lipid-particulate system: in vivo assessment in mice
Weizhi Xu, Faheem Maqbool, Vinod Kumar, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 10, 2005
Increased potency of a novel complement factor 5a receptor antagonist in a rat model of inflammatory bowel disease
Trent M Woodruff, Sandra Pollitt, Lavinia M Proctor, et al.
Inorganic Chemistry
|
June 1, 2014
Flexible binding of PNP pincer ligands to monomeric iron complexes
Kathlyn L Fillman, Elizabeth A Bielinski, Timothy J Schmeier, et al.
Brain Communications
|
October 9, 2020
Monocytes and neutrophils are associated with clinical features in amyotrophic lateral sclerosis
Raquel B McGill, Frederik J Steyn, Shyuan T Ngo, et al.
Journal of Hepatology
|
May 26, 2004
Protective effect of a human C5a receptor antagonist against hepatic ischaemia-reperfusion injury in rats
Thiruma V Arumugam, Trent M Woodruff, Shelli Z Stocks, et al.
The Journal of Infectious Diseases
|
February 21, 2018
Chronic Helminth Infection Perturbs the Gut-Brain Axis, Promotes Neuropathology, and Alters Behavior
Paul R Giacomin, Ann Katrin Kraeuter, Eduardo A Albornoz, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 30, 2009
Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer's disease
Maria I Fonseca, Rahasson R Ager, Shu-Hui Chu, et al.
Page
of 45